Hikma Should Face Amarin's Patent Suit, Magistrate Says

Law360
ADVERTISEMENT
Hikma Should Face Amarin's Patent Suit, Magistrate Says
Law360 (August 3, 2021, 8:54 PM EDT) -- Hikma Pharmaceuticals should not be able to dodge a lawsuit claiming it encouraged doctors to prescribe its generic version of the heart drug Vascepa for uses covered by a series of Amarin patents, a Delaware federal magistrate judge says.
Magistrate Judge Jennifer L. Hall on Tuesday issued a report and recommendation in a lawsuit filed by Amarin Pharma Inc., Amarin Pharmaceuticals Ireland Ltd. and Mochida Pharmaceutical Co. Ltd. alleging that Hikma induced infringement of three patents.
Specifically, Amarin alleged in the so-called "skinny label" case that Hikma induced doctors to infringe the patents by instructing them to use the Hikma generic...

Related Keywords

Delaware ,United States ,Ireland ,Jenniferl Hall , ,Mochida Pharmaceutical Co ,Amarin Pharma Inc ,Amarin Pharmaceuticals Ireland Ltd ,Hikma Pharmaceuticals ,Judge Jennifer ,Amarin Pharmaceuticals Ireland ,Mochida Pharmaceutical ,டெலாவேர் ,ஒன்றுபட்டது மாநிலங்களில் ,ஐயர்ல்யாஂட் ,அமரின் பார்மா இன்க் ,அமரின் மருந்துகள் ஐயர்ல்யாஂட் லிமிடெட் ,ஹிக்மா மருந்துகள் ,நீதிபதி ஜெனிபர் ,அமரின் மருந்துகள் ஐயர்ல்யாஂட் ,